Aditxt, Inc. Basic Shares Outstanding (Weighted Average)
Aditxt, Inc. (ADTX) reported Basic Shares Outstanding (Weighted Average) of 20.17 thousand shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-05-20
- Aditxt, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 20.17K shares, a 69465.52% increase year-over-year.
- Aditxt, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 80.25K shares, a 4012200.00% increase year-over-year.
- Aditxt, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 43.82K shares, a 1095300.00% increase year-over-year.
- Aditxt, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-06-30 was 2.10M shares, a 29049.81% increase year-over-year.
- Aditxt, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 37.35K shares, a 1867650.00% increase from fiscal 2024.
- Aditxt, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 2.00 shares, a 99.83% decline from fiscal 2023.
- Aditxt, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 1.21K shares, a 97.39% decline from fiscal 2022.
- Aditxt, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 46.37K shares, a 87.86% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 20.17K shares 10-Q · filed 2026-05-20 | 50.21K shares derived: average of 2 quarters · filed 2026-05-20 | 48.08K shares derived: average of 3 quarters · filed 2026-05-20 | 561.48K shares derived: average of 4 quarters · filed 2026-05-20 | ||||
| 2025-12-31 | 80.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 62.03K shares derived: average of 2 quarters · filed 2026-03-31 | 741.92K shares derived: average of 3 quarters · filed 2026-03-31 | 37.35K shares 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | 43.82K shares 10-Q · filed 2025-11-18 | 1.07M shares derived: average of 2 quarters · filed 2025-11-18 | 23.06K shares 10-Q · filed 2025-11-18 | 536.39K shares derived: average of 4 quarters · filed 2026-05-20 | ||||
| 2025-06-30 | 2.10M shares 10-Q · filed 2025-08-14 | 1.41M shares 10-Q · filed 2025-08-14 | 700.58K shares derived: average of 3 quarters · filed 2026-05-20 | 525.43K shares derived: average of 4 quarters · filed 2026-05-20 | ||||
| 2025-03-31 | 29.00 shares 10-Q · filed 2026-05-20 | 703.67K shares 10-Q · filed 2025-05-15 | 15.50 shares derived: average of 2 quarters · filed 2026-05-20 | 11.67 shares derived: average of 3 quarters · filed 2026-05-20 | 1.81K shares derived: average of 4 quarters · filed 2026-05-20 | |||
| 2024-12-31 | 2.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | 3.00 shares derived: average of 2 quarters · filed 2026-03-31 | 2.41K shares derived: average of 3 quarters · filed 2026-03-31 | 2.00 shares 10-K · filed 2026-03-31 | 13.18K shares 10-K · filed 2025-03-31 | |||
| 2024-09-30 | 4.00 shares 10-Q · filed 2025-11-18 | 115.67K shares 10-Q · filed 2024-11-18 | 3.61K shares derived: average of 2 quarters · filed 2025-11-18 | 2.00 shares 10-Q · filed 2025-11-18 | 67.18K shares 10-Q · filed 2024-11-18 | 97.75 shares derived: average of 4 quarters · filed 2025-11-18 | ||
| 2024-06-30 | 7.21K shares 10-Q · filed 2025-08-14 | 1.80M shares 10-Q · filed 2024-08-19 | 6.83K shares 10-Q · filed 2025-08-14 | 1.71M shares 10-Q · filed 2024-08-19 | 129.00 shares derived: average of 3 quarters · filed 2025-08-14 | 1.37K shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 161.00 shares 10-Q · filed 2025-05-15 | 1.61M shares 10-Q · filed 2024-05-20 | -3.41K shares derived: average of 2 quarters · filed 2025-05-15 | -580.67 shares derived: average of 3 quarters · filed 2025-05-15 | 38.18K shares derived: average of 4 quarters · filed 2025-05-15 | |||
| 2023-12-31 | -6.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -951.50 shares derived: average of 2 quarters · filed 2025-03-31 | 50.85K shares derived: average of 3 quarters · filed 2025-03-31 | 1.21K shares 10-K · filed 2025-03-31 | 302.36K shares 10-K · filed 2024-04-16 | |||
| 2023-09-30 | 5.08K shares 10-Q · filed 2024-11-18 | 203.25K shares 10-Q · filed 2023-11-14 | 79.76K shares derived: average of 2 quarters · filed 2024-11-18 | 3.94K shares 10-Q · filed 2024-11-18 | 157.58K shares 10-Q · filed 2023-11-14 | 94.51K shares derived: average of 4 quarters · filed 2024-11-18 | ||
| 2023-06-30 | 154.45K shares 10-Q · filed 2024-08-19 | 6.18M shares 10-Q · filed 2023-08-14 | 134.37K shares 10-Q · filed 2024-08-19 | 5.37M shares 10-Q · filed 2023-08-14 | 124.31K shares derived: average of 3 quarters · filed 2024-08-19 | 102.19K shares derived: average of 4 quarters · filed 2024-08-19 | ||
| 2023-03-31 | 114.07K shares 10-Q · filed 2024-05-20 | 4.56M shares 10-Q · filed 2023-05-15 | 109.25K shares derived: average of 2 quarters · filed 2024-05-20 | 84.78K shares derived: average of 3 quarters · filed 2024-05-20 | 291.38K shares derived: average of 4 quarters · filed 2024-05-20 | |||
| 2022-12-31 | 104.42K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | 70.13K shares derived: average of 2 quarters · filed 2024-04-16 | 350.49K shares derived: average of 3 quarters · filed 2024-04-16 | 46.37K shares 10-K · filed 2024-04-16 | 1.85M shares 10-K · filed 2023-04-17 | |||
| 2022-09-30 | 35.83K shares 10-Q · filed 2023-11-14 | 1.43M shares 10-Q · filed 2022-11-14 | 473.52K shares derived: average of 2 quarters · filed 2023-11-14 | 27.02K shares 10-Q · filed 2023-11-14 | 1.08M shares 10-Q · filed 2022-11-14 | 612.41K shares derived: average of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | 911.21K shares 10-Q · filed 2023-08-14 | 45.56M shares 10-Q · filed 2022-08-15 | 901.47K shares 10-Q · filed 2023-08-14 | 45.07M shares 10-Q · filed 2022-08-15 | 804.61K shares derived: average of 3 quarters · filed 2023-08-14 | 690.36K shares derived: average of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | 891.61K shares 10-Q · filed 2023-05-15 | 751.30K shares derived: average of 2 quarters · filed 2023-05-15 | 616.74K shares derived: average of 3 quarters · filed 2023-05-15 | 4.10M shares derived: average of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | 611.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17 | 479.30K shares derived: average of 2 quarters · filed 2023-04-17 | 5.17M shares derived: average of 3 quarters · filed 2023-04-17 | 381.81K shares 10-K · filed 2023-04-17 | ||||
| 2021-09-30 | 347.61K shares 10-Q · filed 2022-11-14 | 7.46M shares derived: average of 2 quarters · filed 2022-11-14 | 305.42K shares 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | 14.56M shares 10-Q · filed 2022-08-15 | 14.20M shares 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |